There is broad agreement that some guardrails around kratom/7-OH are needed, but there is disagreement about what those regulations should be.

The context:

The details: Addiction experts note that classifying 7-OH as a Schedule I drug is not a perfect solution.

But: Other approaches, such as a more rigorously regulated marketplace, may be difficult to accomplish.

The main point: There is major risk in having kratom and highly concentrated products widely available and easily accessible, particularly to young people. Properly regulating kratom can help minimize harm.

Read more: Kratom and 7-OH should be regulated, experts agree. They’re split on how